Korsana Biosciences, Inc. (KRSA)
31.65
+0.37
(+1.18%)
USD |
NASDAQ |
Nov 13, 16:00
31.58
-0.07
(-0.22%)
After-Hours: 19:59
Korsana Biosciences Shareholders Equity (Quarterly) : 416.53M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 416.53M |
| June 30, 2026 | 5.087M |
| March 31, 2026 | 6.791M |
| December 31, 2025 | 9.085M |
| September 30, 2025 | 9.538M |
| June 30, 2025 | 8.57M |
| March 31, 2025 | 8.78M |
| December 31, 2024 | 8.85M |
| September 30, 2024 | 8.198M |
| June 30, 2024 | 8.783M |
| March 31, 2024 | 9.923M |
| December 31, 2023 | 11.29M |
| September 30, 2023 | 12.87M |
| June 30, 2023 | 5.15M |
| March 31, 2023 | 3.925M |
| December 31, 2022 | 10.45M |
| September 30, 2022 | 16.52M |
| June 30, 2022 | 25.36M |
| Date | Value |
|---|---|
| March 31, 2022 | 37.03M |
| December 31, 2021 | 48.25M |
| September 30, 2021 | 56.39M |
| June 30, 2021 | 65.22M |
| March 31, 2021 | 48.43M |
| December 31, 2020 | 59.49M |
| September 30, 2020 | 75.35M |
| June 30, 2020 | 66.10M |
| March 31, 2020 | 81.54M |
| December 31, 2019 | 97.73M |
| September 30, 2019 | 119.20M |
| June 30, 2019 | 141.19M |
| March 31, 2019 | -7.752M |
| December 31, 2018 | -10.44M |
| September 30, 2018 | -8.12M |
| June 30, 2018 | -8.609M |
| March 31, 2018 | |
| December 31, 2017 | -8.567M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Q32 Bio, Inc. | 287.67M |
| IRulya Therapeutics, Inc. | 143.75M |
| Climb Bio, Inc. | 228.05M |
| PepGen Inc. | 103.07M |
| Bridgebio Oncology Therapeutics, Inc. | 293.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 462.08M |
| Total Liabilities (Quarterly) | 45.56M |
| Debt to Equity Ratio | 0.0031 |
| Current Ratio | 10.42 |
| Net Debt Paydown Yield | -0.02% |